Back to Search
Start Over
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors
- Source :
- Breast Care, 17(2), 208-223. KARGER, Scientia, Breast Care (Basel)
- Publication Year :
- 2021
- Publisher :
- S. Karger AG, 2021.
-
Abstract
- Breast cancer; Evidence-generating care; Risk-adjusted prevention Cáncer de mama; Atención generadora de evidencia; Prevención ajustada al riesgo Càncer de mama; Atenció generadora d'evidències; Prevenció ajustada al risc Background: Risk-adjusted cancer screening and prevention is a promising and continuously emerging option for improving cancer prevention. It is driven by increasing knowledge of risk factors and the ability to determine them for individual risk prediction. However, there is a knowledge gap between evidence of increased risk and evidence of the effectiveness and efficiency of clinical preventive interventions based on increased risk. This gap is, in particular, aggravated by the extensive availability of genetic risk factor diagnostics, since the question of appropriate preventive measures immediately arises when an increased risk is identified. However, collecting proof of effective preventive measures, ideally by prospective randomized preventive studies, typically requires very long periods of time, while the knowledge about an increased risk immediately creates a high demand for action. Summary: Therefore, we propose a risk-adjusted prevention concept that is based on the best current evidence making needed and appropriate preventive measures available, and which is constantly evaluated through outcome evaluation, and continuously improved based on these results. We further discuss the structural and procedural requirements as well as legal and socioeconomical aspects relevant for the implementation of this concept. The project was funded by the German Federal Ministry of Health (grant No. 2515FSB401 to Rita Schmutzler and Christiane Woopen) for supporting the international expert meetings, and a grant of the EU Horizon 2020 program, BRIDGES (grant No. 634935, PI Peter Devilee, WP5-PI Rita Schmutzler), for the compilation of the most recent findings of genetic risk prediction.
- Subjects :
- ELSI ethical
Otros calificadores::Otros calificadores::/prevención & control [Otros calificadores]
medicine.medical_specialty
social implications
Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES]
diagnóstico::diagnóstico precoz::detección precoz del cáncer [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS]
Review Article
Risk-adjusted prevention
técnicas de investigación::métodos epidemiológicos::estadística como asunto::probabilidad::riesgo::factores de riesgo [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS]
Individual risk
Other subheadings::Other subheadings::/prevention & control [Other subheadings]
Breast cancer
ddc:150
Cancer screening
Medicine
Mama - Càncer - Diagnòstic
Intensive care medicine
Settore MED/42 - IGIENE GENERALE E APPLICATA
legal
Risk adjusted
neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES]
Cancer prevention
business.industry
Early disease
Evidence-generating care
Mama - Càncer - Factors de risc
Increased risk
Mama - Càncer - Prevenció
Oncology
Preventive intervention
Risk-adjusted prevention · Breast cancer · Evidencegenerating care · ELSI ethical, legal, social implications
Surgery
Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT]
Genetic risk factor
business
ELSI ethical, legal, social implications
Diagnosis::Early Diagnosis::Early Detection of Cancer [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT]
Subjects
Details
- ISSN :
- 16613805 and 16613791
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Breast Care
- Accession number :
- edsair.doi.dedup.....d8294083e3c23fef72ffaee788a52f93